Effect of the abca1 agonist cs-6253 on amyloid-β and lipoproteins metabolism in cynomolgus monkeys

HIGHLIGHTS

• who: Sasan D. Noveir from the Los Angeles, CA, USA Departments of Medicine and Neurology, University of Southern California have published the paper: Effect of the ABCA1 agonist CS-6253 on amyloid-u03b2 and lipoproteins metabolism in cynomolgus monkeys, in the Journal: (JOURNAL)
• what: The aim of this study was to investigate the effects of the ABCA1 agonist peptide CS-6253 on amyloid-u03b2 peptides (Au03b2) and lipoproteins in plasma and cerebrospinal fluid (CSF) of cynomolgus monkeys a species with amyloid and lipoprotein metabolism similar to humans.
• how: The authors hypothesized that treatment . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.